CfDNA as a surrogate marker for COVID-19 severity in patients with influenza-like symptoms with and without SARS-CoV-2 infection in general practice: a prospective cohort study.

Virol J · 2025 · PMC12667079 · PMID 41327284

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

Between t0 and t2, there was a highly significant increase in leukocytes in the COVID group (t0: m = 5.50 [± 1.75] 10 ˄ 3/μl; t2: m = 7.38 [± 2.4] 10 ˄ 3/μl; t(29) = −7.426, p < 0.001), and the increase in leukocytes between t0 and t1 (t1: m = 6.73 [± 2.34] 10 ˄ 3/μl; t(30) = −4.204, p < 0.001) and t1 and t2 was also significant (t(29) = −2.948, p = 0.019).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.